Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer

Clinical trial NCT06475326 · RECRUITING

Trial details

NCT number: NCT06475326
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2024-06-05
Primary completion: 2025-06-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.